Polyneuron Pharmaceuticals, a BaseLaunch participant, has successfully raised over 3 million Swiss francs in a financing round. The Basel-based pharmaceutical company is developing an active substance for the treatment of the autoimmune disease anti-MAG neuropathy, among others. Polyneuron Pharmaceuticals has announced the closing of a 3.1 million Swiss...

Protecting an invention is absolutely key and one of the first steps on the route towards commercializing promising research.  Additionally, where the IP is owned by the university hosting the inventor, in order for any investor to put real money into the company, one has...

The very first steps on the road from bench to bedside Protecting an invention is absolutely key and one of the first steps on the route towards commercializing promising research.  Additionally, where the IP is owned by the university hosting the inventor, in order for any...

A gene therapy startup company The startup headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup captured investors’ attention by suggesting it knows a better way to do gene transfer. Generation Bio is the Boston/Cambridge upstart. ...